期刊文献+

男性慢性阻塞性肺疾病炎性因子肌肉抑制素与体重指数FEV_1占预计值百分比的关系 被引量:4

Relations of serum myostatin and inflammatory factors with BMI and FEV_1/predicted in chronic obstructive pulmonary disease
原文传递
导出
摘要 目的研究稳定期慢性阻塞性肺疾病(慢阻肺)患者血清中炎性因子、肌肉抑制素、第一秒用力呼气容积占预计值的百分比(FEV1%pred)、体重指数(BMI)情况及相关性。方法选择2010-2012年重庆市稳定期慢阻肺男性患者及年龄相仿的健康者,用酶联免疫吸附法测定血清肿瘤坏死因子(TNF)-α、白介素(IL)-6、肌肉抑制素;肺功能仪器检测每位受试者的FEV1%pred;测定身高及体重,计算BMI。慢阻肺患者分别根据FEV1%pred及BMI分组,比较慢阻肺患者与健康受试者相关指标,探讨血清炎症因子、FEV1%预计值与肌肉抑制素的相关性。结果根据FEV1%pred及BMI分组(F组/T组)的慢阻肺组患者血清中TNF-α、IL-6及肌肉抑制素水平较对照组均有升高,除F1组/T1组外,差异有统计学意义(P<0.01),肺功能越差,BMI越低,TNF-α、IL-6及肌肉抑制素水平越高(P<0.05)。TNF-α、IL-6与肌肉抑制素正相关(P<0.05),FEV1%pred与肌肉抑制素负相关(P<0.05)。结论慢阻肺患者肺功能越差,BMI越低者,炎性因子及肌肉抑制素水平越高;炎性因子水平越高者,肌肉抑制素水平越高;肌肉抑制素水平越高者,反应肌肉萎缩越严重,肺功能越差,病情越重。炎性因子及肌肉抑制素可能成为慢阻肺患者潜在治疗的靶点。 Objective To study the relation of serum myostatin and inflammatory factor with BMI and FEV1/predicted in male patients with chronic obstructive pulmonary disease. Methods A cohort of outpatients with stable COPD and health volunteers were evaluated.We evaluated interleukin-6(IL-6),tumor necrosis factor-α(TNF-α),myostatin,FEV1%pred and body mass index(BMI), and stratified for FEV1/pred and BMI.Plasma concentrations of IL-6,TNF-α and myostatin were measured by high sensitivity ELISA. Results The concentrations of TNF-α,IL-6 and myostatin increased significantly in different groups except for F1/B1 group as compared with control group(P〈0.001).When stratified for FEV1%predicted or BMI,serum myostatin levels were correlated inversely with FEV1/predicted(P〈0.05);there was a positive correlation between myostatin and TNF-α/IL-6 in serum(P〈0.05). Conclusion Patients with lower FEV1/pred value have a lower BMI and higher inflammatory factor and higher myostatin level.Patients with a higher inflammatory factor level had a higher myostatin levels.Patients with higher myostatin levels(significantly more muscle atrophy)have a lower FEV1/pred value,incident with worse pathogenetic condition.Inflammatory factors and myostatin may become potential treatment target in COPD.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2015年第1期56-59,共4页 Chinese Journal of Practical Internal Medicine
基金 国家自然科学基金(81370111)
关键词 慢性阻塞性肺疾病 体重指数 肿瘤坏死因子 白介素-6 肌肉抑制素 chronic obstructive pulmonary disease BMI tumor necrosis factor interleukin-6 myostatin
  • 相关文献

参考文献15

  • 1Johnston RA, Schwartzman IN, Flynt L, et al. Role of interleukin-6 in murine airway responses to ozone[J]. Physiol Lung Cell Mol Physiol, 2005, 288(2): 390-397.
  • 2Janssen SPM, Gayan-Ramirez G, Van Den Bergh A, et al. Interlenkin-6 causes myocardial failure and skeletal muscle atrophy in rats[J].Circulation, 2005, 111 (8): 996-1005.
  • 3Deveci Y, Deveci F, Ilhan N, Serum ghrelin, et al. IL-6 and TNF-a levels in patients with chronic obstructive pulmonary disease[J]. Tuberk Toraks, 2010, 58(2): 162-172.
  • 4Yang W, Zhang Y, Li Y, et al. Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase/AKT/ GSK-3: pathway and is antagonized by insulin-like growth factor l[J]. Biol Chem, 2007, 282(6): 3799-3808.
  • 5Plant PJ, Brooks D,Faughnan M, et al. Cellular markers of muscle atrophy in chronic obstructive pulmonary disease[J]. Respir Cell Mol Biol, 2010, 42(4): 461-471.
  • 6Testelmans D, Crul T, Maes K, et al. Atrophy and hypertrophy signaling in the diaphragm of patients with C OPD [J]. Eur Respir, 2010, 35(3): 549-556.
  • 7Hasselgren PO. Glucocorticoids and muscle metabolism[J]. Curr Opin Clin Nutr Metab Care, 1999, 2(3): 201-205.
  • 8Gilson H, Schakman O, Combaret L, et al. Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy[J]. Endocrinology, 2007, 148(1): 452-460.
  • 9Hayot M, Rodriguez J, Vernus B, et al. Myostatin up-regulation isassociated with the skeletal muscle response to hypoxic stimuli[J]. Mol Cell Endocrinol, 2011, 332( 1-2): 38-47.
  • 10Zhang L, DuJ, Hu Z, et al. IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting[J]. Am Soc Nephrol, 2009, 20(3): 604-612.

同被引文献31

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部